Affini-T Therapeutics
Focus: Affini-T Therapeutics is a pre-revenue biotech company focused on TCR (T-cell receptor) cell therapy for solid tumors and hematologic malignancies. The company is based in Watertown, MA and operates in the highly competitive cell and gene therapy space.
Profile data last refreshed 15h ago · AI intelligence enriched 2w ago
Open Jobs
0
About Affini-T Therapeutics
AI assessmentNot HiringNo open roles listed right now. Follow Affini-T Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
6 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Bendamustine
Metastatic Malignant Solid NeoplasmClinical Trials (1)
NCT06043713Autologous CD8+ and CD4+ Transgenic T Cells Expressing High Affinity KRASG12V Mutation-Specific T Cell Receptors (FH-A11KRASG12V-TCR) in Treating Patients With Metastatic Solid Tumor Cancers With KRAS G12V Mutations
Phase 1Help build intelligence for Affini-T Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.